Latest Breaking News On - Trustees at action for pulmonary fibrosis - Page 1 : comparemela.com

/PRNewswire/ Trevi Therapeutics, Inc. (Nasdaq: TRVI) is a clinical-stage biopharmaceutical company developing an investigational therapy Haduvio™.

United statesUnited kingdomSteve jonesRosalia scampoliKatie mcmanusHc wainwright bioconnectDevelopment officerPrnewswire trevi therapeutics incTrustees at action for pulmonary fibrosisExchange commissionEuropean pulmonary fibrosis federationTrevi therapeutics incBill forbesChief developmentPulmonary fibrosisLiam galvin